1-2 of 2
Anna Lucania
Close
Sort by
Journal Articles

Lenalidomide in Pretreated Mantle Cell Lymphoma Patients: An Italian Observational Multicenter Retrospective Study in Daily Clinical Practice, the Lenamant Study

Vittorio Stefoni, Cinzia Pellegrini, Letizia Gandolfi, Luca Baldini, Monica Tani, Emanuele Cencini, Amalia Figuera, Michela Ansuinelli, Elisa Bernocco, Maria Cantonetti, M. Christina Cox, MD, Filippo Ballerini, MD, Chiara Rusconi, MD, Carlo Visco, MD, Luca Arcaini, Angela Fama, Roberto Marasca, Francesco Zaja, Alessia Castellino, Catello Califano, Marina Cavaliere, Guido Gini, MD, Anna Marina Liberati, Gerardo Musuraca, MD, Anna Lucania, Giuseppina Ricciuti, Lisa Argnani, Pier Luigi Zinzani, MD PhD
Journal: Blood
Blood (2015) 126 (23): 3946.
https://doi.org/10.1182/blood.V126.23.3946.3946
Published: 2015
Journal Articles

Biweekly Rituximab, Cyclophosphamide, Vincristine, Non-Pegylated Liposome-Encapsulated Doxorubicin (Myocet®) and Prednisone (R-COMP-14) as Induction Treatment in Poor R-IPI Risk Elderly Patients with Diffuse Large B-Cell Lymphoma (DLBCL) and Pre-Existing Heart Disease.

Ferdinando Frigeri, MD, Gaetano Corazzelli, MD, Manuela Arcamone, MD, Gaetana Capobianco, MD, Anna Lucania, MD, Cristina Becchimanzi, MD, Gianpaolo Marcacci, MD, Filippo Russo, MD, Maria Rosaria Villa, MD, Lucia Mastrullo, MD, Antonio Pinto, MD
Journal: Blood
Blood (2009) 114 (22): 1664.
https://doi.org/10.1182/blood.V114.22.1664.1664
Published: 2009